The combined market capitalisation of Samsung Group's affiliates dropped about 23 per cent in 2024 due to the sluggish performance of its key affiliate Samsung Electronics, data showed on Sunday.

SEOUL, Dec. 30 (Korea Bizwire) — Samsung Group, South Korea’s largest conglomerate, has seen its market capitalization ...

Samsung Group has 22 affiliates listed on the local stock market, including Samsung Electronics Co., Samsung Biologics Co., ...

Samsung Group's market capitalization has decreased by over 160 trillion won this year. According to the financial investment ...

Denosumab biosimilar is under clinical development by Samsung Bioepis and currently in Phase III for Post Menopausal Osteoporosis.

Samsung invests in Generate to advance AI-driven protein therapeutics discovery: Incheon, South Korea Saturday, December 21, 2024, 17:00 Hrs [IST] Samsung announced that it has in ...

Samsung Biologics has signed a contract worth 111.2 billion won with an undisclosed U.S. pharmaceutical firm to provide ...

"We see great potential in Generate to develop first- and best-in-class therapeutics," said John Rim, President and CEO of ...

Samsung Biologics was recognized for its dedication to embed sustainable business practices across its operations, particularly robust environmental efforts, including progress toward achieving ...

Samsung Biologics announced on the 17th that it has been included in the Dow Jones Sustainability Indices World for four consecutive years. The Dow Jones Sustainability Indices World is a global ...

Samsung Biologics Logo (PRNewsfoto/Samsung Biologics) Samsung Biologics was recognized for its dedication to embed sustainable business practices across its operations, particularly robust ...